These results are consistent with clinical observations that deregulation of ErbB-PI3K signaling elements can elicit distinct responses40 and highlights the ability of this platform to reveal specific morphogenic behaviors associated with distinct breast cancer-associated genetic alterations. This evidence concerns the gene EGFR and breast cancer.